What is the global market size of Cardiovascular Devices Market?

Global Cardiovascular Devices Market size was valued at USD 17.822 billion in 2021 and is poised to grow from USD 18.8 billion in 2022 to USD 31.1 billion by 2030, growing at a CAGR of 5.5% in the forecast period (2023-2030).

Who are the key vendors in the Global Cardiovascular Devices Market?

The cardiovascular devices market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses to increase market share and profitability. 'Abbott Laboratories', 'Boston Scientific Corporation', 'Medtronic, Inc.', 'St. Jude Medical, Inc.', 'Johnson & Johnson', 'Terumo Corporation', 'Edwards Lifesciences Corporation', 'Biotronik SE & Co. KG', 'LivaNova PLC', 'Getinge AB', 'Hill-Rom Holdings, Inc.', 'Koninklijke Philips N.V.', 'Siemens Healthineers AG', 'GE Healthcare', 'Toshiba Corporation', 'Fujifilm Holdings Corporation', 'Hitachi, Ltd.', 'Nihon Kohden Corporation', 'Cardiac Science Corporation', 'Schiller AG'.

What is the key driver of Global Cardiovascular Devices Market?

Rise in the Prevalence of Cardiovascular Diseases to Boost the Global Market

What is the key market trend for Global Cardiovascular Devices Market?

High Demand for Advanced Features in Cardiovascular Devices

Which region accounted for the largest share in Global Cardiovascular Devices Market?

On the basis of region, the global cardiovascular devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Cardiovascular Devices Market Size, Share, Growth Analysis, By Device(Diagnostic, Monitoring Devices, Therapeutic, surgical devices), By Application(Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure), By End user(Hospitals, Specialty Clinics, Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35E2016 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 91 | Figures: 76

Cardiovascular Devices Market News

October 2022: Medtronic plc received United States FDA approval to expand cardiac lead labeling by stimulating the heart’s natural electrical current, allowing patients to receive the treatment.
March 2024: Stryker introduced the LIFEPAK CR2 AED and evacuation chair for cardiac monitoring. The LIFEPAK CR2 helps rescuers quickly deliver CPR and shock in the event of sudden cardiac arrest, with the quick deployment of QUIK-STEP electrodes and a Shock Advisory System for ECG monitoring.
October 2022: Biosense Webster, Inc., a division of Johnson & Johnson MedTech, launched the HELIOSTAR balloon ablation catheter in Europe. The HELIOSTAR balloon ablation catheter is indicated for use in catheter-based cardiac electrophysiological mapping (and stimulation and recording) of the atria, and when used with a compatible multichannel RF generator, for use in the heart.

Cardiovascular Devices Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cardiovascular Devices Market size was valued at USD 17.822 billion in 2019 and is poised to grow from USD 18.8 billion in 2023 to USD 31.1 billion by 2031, growing at a CAGR of 5.5% in the forecast period (2024-2031).

The cardiovascular devices market is competitive, dominated by established medical technology companies and driven by continuous innovation, a collaborative approach and a focus on expanding global reach. These agencies have constructed a vast market percentage via complicated cardiovascular solutions, from implantable devices together with pacemakers and stents to advanced imaging systems. Key players use partnerships and acquisitions to gain competitive benefit and drive growth. 'Abbott Laboratories', 'Boston Scientific Corporation', 'Medtronic, Inc.', 'St. Jude Medical, Inc.', 'Johnson & Johnson', 'Terumo Corporation', 'Edwards Lifesciences Corporation', 'Biotronik SE & Co. KG', 'LivaNova PLC', 'Getinge AB', 'Hill-Rom Holdings, Inc.', 'Koninklijke Philips N.V.', 'Siemens Healthineers AG', 'GE Healthcare', 'Toshiba Corporation', 'Fujifilm Holdings Corporation', 'Hitachi, Ltd.', 'Nihon Kohden Corporation', 'Cardiac Science Corporation', 'Schiller AG'

Worldwide, cardiovascular diseases (CVDs) are the leading cause of death, driving the demand for advanced medical devices. Sedentary lifestyles, poor dietary intake, and an aging population increase the risk of cardiovascular conditions such as congestive heart failure, heart failure and hypertension. Consequently, life-saving devices such as pacemakers, defibrillators and stents are increasingly needed in developed and developing areas as health systems prioritize preventive care with early detection of disease. Hospitals and clinics following the pace of using cutting-edge technology to improve patient outcomes, government programs and nonprofits are launching programs to raise awareness of high-risk populations have been monitored.

Expanding Home Health Solutions: Trends in home healthcare and self-management are changing the cardiovascular devices market. Wearable ECG devices, blood pressure monitors, and remote patient monitoring methods provide real-time data, allowing individuals to manage chronic heart failure without repeated hospital visits. This trend is not to make patients not only easier, reducing the healthcare costs but supporting the transition to preventative healthcare.

As per cardiovascular devices market outlook, North America dominated the market and accounted for the largest revenue share at 47.7% in 2024, driven by rising atrial fibrillation (AFib) & cardiovascular disease (CVD), supportive government policies and the technological advancements. This atrial fibrillation (AF) is very common, which is considered a risk factor for it has a lifetime incidence of approximately 1 in 3 to 5 people over the age of 45. AFib leads to significant hospitalization and death establish the urgent need for advanced cardiovascular emphasis devices each year. The market has grown with the increase in the prevalence of AFIB among older people in Canada. Important government initiatives supporting health promotion such as national research networks and provincial investments.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Cardiovascular Devices Market News

Cardiovascular Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cardiovascular Devices Market?

Who are the key vendors in the Cardiovascular Devices Market?

What is the key driver of Cardiovascular Devices Market?

What is the key market trend for Cardiovascular Devices Market?

Which region accounted for the largest share in Cardiovascular Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300